SPRY Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in ARS Pharmaceuticals Inc. Securities Class Action - Contact SueWallSt
A securities class action alleges ARS Pharmaceuticals misrepresented when expanded CVS Caremark coverage for neffy would take effect; SPRY purchasers retain specific rights, including the option to seek lead plaintiff appointment or remain absent class members. NEW YORK, Sept. 24, 2026...
Covered in this story
What has happened since
- Ars Pharmaceuticals Inc is up 4.1% since this was published, 28 days ago.
- CVS Health is up 11.1% since this was published, 28 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $SPRY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ars Pharmaceuticals Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.